Antiviral agents

Details Antiviral agents Antiviral agents

2006-11-13

2010-11-09

Balasubramanian, Venkataraman (Department: 1624)

Organic compounds -- part of the class 532-570 series

Organic compounds

Four or more ring nitrogens in the bicyclo ring system

C514S252030

Reexamination Certificate

active

07829705

ABSTRACT:
This invention relates to compounds of formula Itheir salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals, as well as novel intermediates useful in the preparation of the compounds of formula I.

REFERENCES:
patent: 3997565 (1976-12-01), Kauer
patent: 4268678 (1981-05-01), Diana et al.
patent: 4451476 (1984-05-01), Diana
patent: 4472416 (1984-09-01), Stetter et al.
patent: 4843087 (1989-06-01), Diana
patent: 4857539 (1989-08-01), Diana et al.
patent: 4861791 (1989-08-01), Diana et al.
patent: 4939267 (1990-07-01), Diana
patent: 4942241 (1990-07-01), Diana et al.
patent: 4945164 (1990-07-01), Diana
patent: 4956351 (1990-09-01), Mesens et al.
patent: 4992433 (1991-02-01), Stokbroekx et al.
patent: 5001125 (1991-03-01), Stokbroekx et al.
patent: 5002960 (1991-03-01), Diana
patent: 5051437 (1991-09-01), Diana
patent: 5070090 (1991-12-01), Stokbroekx et al.
patent: 5100893 (1992-03-01), Stokbroekx et al.
patent: 5106973 (1992-04-01), Stokbroekx et al.
patent: 5110821 (1992-05-01), Diana
patent: 5112825 (1992-05-01), Stokbroekx et al.
patent: 5175178 (1992-12-01), Diana et al.
patent: 5196535 (1993-03-01), Stokbroekx et al.
patent: 5231184 (1993-07-01), Stokbroekx et al.
patent: 5242924 (1993-09-01), Diana
patent: 5349068 (1994-09-01), Diana et al.
patent: 5364865 (1994-11-01), Diana
patent: 5453433 (1995-09-01), Aldous et al.
patent: 5464848 (1995-11-01), Diana et al.
patent: 5514679 (1996-05-01), Aldous et al.
patent: 5514692 (1996-05-01), Aldous et al.
patent: 5523312 (1996-06-01), Aldous et al.
patent: 5552420 (1996-09-01), Aldous et al.
patent: 5567717 (1996-10-01), Aldous et al.
patent: 5567719 (1996-10-01), Aldous et al.
patent: 5618821 (1997-04-01), Aldous et al.
patent: 5643929 (1997-07-01), Diana et al.
patent: 5650419 (1997-07-01), Aldous et al.
patent: 5665763 (1997-09-01), Aldous et al.
patent: 5721261 (1998-02-01), Aldous et al.
patent: 5750527 (1998-05-01), Aldous et al.
patent: 5763461 (1998-06-01), Aldous et al.
patent: 5821257 (1998-10-01), Aldous et al.
patent: 5846986 (1998-12-01), Aldous et al.
patent: 7166604 (2007-01-01), Watson et al.
patent: 0 248 253 (1987-12-01), None
patent: 0 290 906 (1988-11-01), None
patent: 0 435 381 (1991-07-01), None
patent: 0 398 425 (1994-03-01), None
patent: 0 398 427 (1994-03-01), None
patent: 62-252783 (1987-11-01), None
patent: 1-207278 (1989-08-01), None
patent: 2104584 (1990-04-01), None
patent: 3-47174 (1991-02-01), None
patent: 3-47182 (1991-02-01), None
patent: 3-56484 (1991-03-01), None
patent: 3-200771 (1991-09-01), None
patent: 4-128283 (1992-04-01), None
patent: 5-320117 (1993-12-01), None
patent: 8-81314 (1996-03-01), None
patent: 2000-500773 (2000-01-01), None
patent: 2003-517481 (2003-05-01), None
patent: WO 90/01874 (1990-03-01), None
patent: WO 95/04723 (1995-02-01), None
patent: WO 96/04270 (1996-02-01), None
patent: WO 97/23216 (1997-07-01), None
patent: WO 97/46236 (1997-12-01), None
patent: WO 98/11095 (1998-03-01), None
patent: WO 98/17631 (1998-04-01), None
patent: WO 98/55120 (1998-12-01), None
patent: WO 99/24440 (1999-05-01), None
patent: WO 99/55663 (1999-11-01), None
patent: WO 99/59587 (1999-11-01), None
patent: WO 00/18761 (2000-04-01), None
patent: WO 00/21927 (2000-04-01), None
patent: WO 00/78746 (2000-12-01), None
patent: WO 01/19822 (2001-03-01), None
patent: WO 01/38313 (2001-05-01), None
patent: WO 01/38314 (2001-05-01), None
patent: WO 01/43740 (2001-06-01), None
Hayden , F. G., Review in Medical Virology, 14, 17-31, 2004.
Wolff Manfred E. “Burger's Medicinal Chemistry, 5ed, Part 1”, John Wiley & Sons, 1995, pp. 975-977.
Banker, G.S. et al, “Modern Pharmaceutices, 3ed.”, Marcel Dekker, New York. 1996, p. 596.
Adams and Merluzzi (eds.), “The Search for Antiviral Drugs: Case Histories from Concept to Clinic,” Birkhouse, Boston, 1993, Chapter 8, pp. 179-209.
Diana et al., “Antipicornavirus Drugs: Current Status,” Antiviral Chemistry and Chemotherapy 8(5):401-408, 1997.
Hayden et al., “Intranasal Pirodavir (R77,975) Treatment of Rhinovirus Colds,” Antimicrobial Agents and Chemotherapy 39(2):290-294, Feb. 1995.
Hayden et al., “Safety and Efficacy of Intranasal Pirodavir (R77975) in Experimental Rhinovirus Infection,” Antimicrobial Agents and Chemotherapy 36(4):727-732, Apr. 1992.
Malamas et al., “Azole Phenoxy Hydroxyureas as Selective and Orally Active Inhibitors of 5-Lipoxygenase,” J. Med. Chem. 39:237-425, 1996.
Patani et al., “Bioisosterism: A Rational Approach in Drug Design” Chemical Reviews 96(8):3147-3176, Dec. 1996.
Starling et al., “Anti-Inflammatory & Anti-Arrhythmic Activities of I-(Alkanoylphenoxy/Thiophenoxy)-3-(N4-phenylpiperazinyl)propanes,” Indian Journal of Chemistry 15B:715-719, Aug. 1977.
Strupczewski et al., “3-[[(Aryloxy)alkyl]piperidinyl]-1,2-Benzisoxazoles as D2/5-Ht2 Antagonists with Potential Atypical Antipsychotic Activity: Antipsychotic Profile of Iloperidone (HP 873),” J. Med. Chem. 38:1119-1131, 1995T.
Zhao et al., “Design, Synthesis, and In Vitro Biological Activity of Benzimidazole Based Factor Xa Inhibitors,”Bioorganic&Medicinal Chemistry Letters10: 963-966, 2000.
Andries et al., “In Vitro Activity of Pirodavir (R 77975), a Substituted Phenoxy-Pyridazinamine with Broad-Spectrum Antipicornaviral Activity,”Antimicrobial Agents and Chemotherapy36(1): 100-107, Jan. 1992.
FDA AVAC Briefing Documentfor Picovir (Pleconaril), NDA 21-245, “Section 4. Microbiology”, items 4.1, 4.2 and 4.3.
Hayden et al., “Safety and Efficacy of Intranasal Pirodavir (R77975) in Experimental Rhinovirus Infection,”Antimicrobial Agents and Chemotherapy36(4): 727-732, Apr. 1992.
Hayden et al., “Efficacy and Safety of Oral Pleconaril for Treatment of Colds Due to Picornaviruses in Adults: Results of 2 Double-Blind, Randomized, Placebo-Controlled Trials,”Clinical Infectious Diseases36: 1523-32, Jun. 15, 2003.
Lewis-Rogers et al., “Phylogenetic Relationships and Molecular Adaptation Dynamics of Human Rhinoviruses,”Mol. Biol. Evol. 26(5): 969-981, 2009.
Pevear et al., “Activity of Pleconaril against Enteroviruses,”Antimicrobial Agents and Chemotherapy43(9): 2109-2115, Sep. 1999.
Schiff et al., “Clinical Activity of Pleconaril in an Experimentally Induced Coxsackievirus A21 Respiratory Infection,”The Journal of Infectious Diseases181: 20-6, Jan. 2000.

Affiliated with

Also associated with

Rating

Antiviral agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiviral agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiviral agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4251290